University Hospital Zurich, Hämatologie
Welcome,         Profile    Billing    Logout  
 5 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ansari, Marc
NCT02670564: ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Recruiting
4
1000
Europe
Pharmacogenomics, DNA analyses, Busulfan plasma level measurements
Swiss Pediatric Oncology Group, ALL SCTped Forum
Acute Lymphoblastic Leukemia
04/21
04/26
PHITT, NCT03017326 / 2016-002828-85: Paediatric Hepatic International Tumour Trial

Active, not recruiting
3
450
Europe, RoW
Cisplatin, Doxorubicin, Carboplatin, 5Fluorouracil, Vincristine, Etoposide, Irinotecan, Gemcitabine, Oxaliplatin, Sorafenib
University of Birmingham, Fundació Institut Germans Trias i Pujol, University Hospital Munich, University Hospital, Bonn, University of Kiel, University Hospital Tuebingen, University of Padova, Ludwig-Maximilians - University of Munich, Medical University of Gdansk, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Motol University Hospital, Prague, Rennes University Hospital, Children's University Hospital, Ireland, University of Oslo, Princess Maxima Center for Pediatric Oncology, Andaluz Health Service, Swiss Pediatric Oncology Group, Gothia Forum - Center for Clinical Trial, The Leeds Teaching Hospitals NHS Trust, Bambino Gesù Hospital and Research Institute, Newcastle University Centre for Cancer, Newcastle, Experimental Cancer Medicine Centres, XenTech, Evry
Hepatoblastoma, Carcinoma, Hepatocellular
08/26
08/27
FORUM, NCT01949129 / 2012-003032-22: Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Recruiting
2/3
1800
Europe, Canada, RoW
VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin
St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group
Acute Lymphoblastic Leukaemia
06/25
04/30
ESPECT, NCT05688241: EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Not yet recruiting
1/2
10
Europe
Donor-derived ex-vivo expanded EBV Tscm CTL
University Hospital, Basel, Switzerland
EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD)
12/25
12/25
NCT01257854: Polymorphisms and Busulfan Pharmacokinetic Study

Recruiting
N/A
200
Europe, Canada
University Hospital, Geneva, European Society for Blood and Marrow Transplantation
Children Who Receive a Stem Cell Transplantation With Busulfan IV
12/23
12/23
GECCOS, NCT04702321: Genetic Risks for Childhood Cancer Complications in Switzerland

Recruiting
N/A
6000
Europe
Procedure: Biospecimen Collection, Medical Chart Review, Procedure: Medical Chart Review, Registry data collection
University Hospital, Geneva
Childhood Cancer, Genetic Predisposition, Late Effect
12/37
12/37
SCCSS-FU, NCT04732273: The Swiss Childhood Cancer Survivor Study - Follow-up (SCCSS-FollowUp)

Recruiting
N/A
3000
Europe
Physical examination, diagnostic tests, laboratory tests, Personal history, questionnaire
University of Bern
Late Effect, Childhood Cancer
01/71
01/71
SWISS-Pearl, NCT05427136: Early Pulmonary Dysfunction in Childhood Cancer Patients

Recruiting
N/A
140
Europe
Lung function measurements, Breath Analysis, Magnetic resonance imaging (MRI), Standardized interview to assess respiratory symptoms, Data collection for assessment of clinical parameters and cumulative doses to chemotherapy, radiation, surgery and HSCT, Collection of genetic samples
University Children's Hospital Basel
Pulmonary Dysfunction
06/51
06/51
Wolfensberger, Nathan
ESPECT, NCT05688241: EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Not yet recruiting
1/2
10
Europe
Donor-derived ex-vivo expanded EBV Tscm CTL
University Hospital, Basel, Switzerland
EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD)
12/25
12/25
Schneidawind, Dominik
ESPECT, NCT05688241: EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Not yet recruiting
1/2
10
Europe
Donor-derived ex-vivo expanded EBV Tscm CTL
University Hospital, Basel, Switzerland
EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD)
12/25
12/25

Download Options